Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus-associated T/NK-cell lymphoproliferative disease
- 2 December 2002
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 44 (3), 251-257
- https://doi.org/10.1016/s1040-8428(02)00116-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Epstein-Barr virus infection and its role in the expanding spectrum of human diseasesActa Paediatrica, 2007
- Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral bloodBone Marrow Transplantation, 2000
- Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.The Lancet, 2000
- Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in JapanBone Marrow Transplantation, 1999
- Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndromeProceedings of the National Academy of Sciences of the United States of America, 1998
- Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding geneNature Genetics, 1998
- The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAMNature, 1998
- Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemiaThe Lancet, 1996
- CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.JCI Insight, 1989
- Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosisCancer, 1979